We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

BIOCARE CORP

BioCare Corporation manufactures and markets medical devices such as electrolyte analyzer, urine analyzer, hospital-g... read more Featured Products: More products

Download Mobile App




Fully Open Automated Slide Staining Instrument Designed for Robust Antibody Staining

By LabMedica International staff writers
Posted on 07 Dec 2023
Print article
Image: intelliPATH+ is the next-generation enhancement of the proven intelliPATH FLX staining system (Photo courtesy of Biocare Medical)
Image: intelliPATH+ is the next-generation enhancement of the proven intelliPATH FLX staining system (Photo courtesy of Biocare Medical)

An advanced staining instrument with state-of-the-art upgrades has been designed for ultimate flexibility and robust antibody staining with rich features for enhanced laboratory usability.

Biocare Medical (Pacheco, CA, USA) has introduced the intelliPATH+ advanced staining instrument, a newly upgraded system featuring the latest technological advancements. This fully open system allows for continuous random access along with immediate STAT capabilities, enhancing the workflow significantly. It is particularly efficient in immunohistochemistry (IHC) staining, providing increased speed, superior quality, and reduced waste. The intelliPATH+ is tailor-made for lab professionals who value the dependability of automated processes but require flexibility for specific needs. It features customizable protocols for each of its 50 slide positions, promoting both precision and efficiency.

The intelliPATH+ boasts a redesigned, scalable user interface that makes laboratory workflow more efficient. This user-friendly interface allows easy navigation with options for pre-set protocols or custom creation, including adjustable dispense volumes from 100µl to 600µl across three different zones. This customization ensures an efficient and personalized staining experience. The system meticulously controls every aspect of the staining process. When combined with Biocare Medical’s latest ARC decloaking chamber, it delivers robust, reproducible, and vivid staining results.

The ARC, specifically designed for Heat-Induced Epitope Retrieval (HIER) and compliant with in vitro diagnostic (IVD) standards, is indispensable for high-quality IHC and in situ hybridization (ISH) staining. It can hold up to 72 standard slides or 27 double-wide slides, offering a broad temperature range from 60°C to 121°C. This capability makes the ARC a crucial tool for both clinical and research settings, ensuring accurate and consistent results. The intelliPATH+, now labeled for IVD use, is available for purchase in the United States and selected international markets.

Related Links:
Biocare Medical

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.